At a glance
- Originator Mitsubishi Pharma Corporation
- Class Adamantanes; Antiplatelets
- Mechanism of Action Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Peripheral vascular disorders
Most Recent Events
- 27 Mar 2001 New profile
- 27 Mar 2001 Preclinical development for Peripheral vascular disorders in Japan (Unknown route)